当前位置: 首页 > 期刊 > 《现代医药卫生》 > 2007年第22期
编号:11503821
血管内皮生长因子及骨桥蛋白联合检测在非小细胞肺癌中的临床研究(3)
http://www.100md.com 2007年11月15日 《现代医药卫生》 2007年第22期
     [7] Hayes DW jr,Webb GE,Mandrachia VJ,et al. Full-thickness bum of the foot :Successful treatmentwith Apligraf, case report[J]. Clin Podiatr Med Sung,2001,18(1):179.

    [8] Allan AL,George R,Vantyghem SA,et al. Role of the integrin-bind-ing protein osteopontin in Lymphatic metastasis of breast cancer[J]. Am J Pathol,2006,169(1):233.

    [9] Zhang DT,Yuan J,Yang L,et al. Osteopontin rxpression and its rela-tion to invasion and metastases in gastric cancer[J]. Zhong Hua Zhong Liu Za Zhi,2005,27(3):167.

    [10] Hirama M,Tarahashi F,Takahasi K,et al.Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tu-mor growth[J]. Cancer Lett,2003,193(2):107.

    [11] Srinivas PR,Kramer BS. Trend in biomarker research for cancer de-tection[J]. Lancen Oncol,2001,2(11):698.

    [12] Shijubo N,Vedo T,Kon S,et al.Vascular endothelial growth factor and osteopontin in stage Ⅱ Lung adenocarcinoma[J].Am J Respir-crit Care Med,2003,160(4):1269.

    [13] Seger DR,Ledbetter SR,Claffry KP,et al. Stimalation of endothelial cell migration by vascular permeability factor / Vascular endothelial growth factor through co-operative mechanisms involving the alphav-beta3 integrin,osteopontin,and thrombin[J]. Am J Pathol,2002,149(1):293.

    [14] Jain S,Chakraborty G. Osteopontin:an emerging therapeutic target for anticancer therapy[J]. Expert Opin Ther Targets,2007,11(1):81.

    收稿日期:2007-07-24, 百拇医药(胡春霞)
上一页1 2 3